Introduction
============

Anemia represents a global problem that affects people from all walks of life in all societies. Around a quarter of the world's population suffers from this disease. The problem is not constrained to the medical sector, and its roots can be traced to education, demography, and nutrition. Iron deficiency accounts for about half of the world's anemia. Anemia has caused 19.7 million years of life adapted with disability. The average annual economic loss incurred as a result of iron deficiency anemia in 10 developing countries is estimated at approximately \$16.78 per capita or 4% of gross domestic product (GDP) \[[@b1-ogs-19196]\].

Although adults only need 1 mg of absorbable iron daily, iron deficiency anemia remains a widespread issue. Women of reproductive age who have poor diets and suffer from malnutrition are at a greater risk for anemia \[[@b2-ogs-19196],[@b3-ogs-19196]\]. The prevalence of iron deficiency anemia in women is higher than that of men. Despite the economic-scientific advances in recent years, anemia is still prevalent especially in pregnant women and children before school age \[[@b4-ogs-19196]\].

The World Health Organization (WHO) estimates that iron deficiency anemia took the lives of 273,000 people in 2004. Of this figure, 45% were Southeast Asian, 31% African, 9% Eastern Mediterranean, 4% Oceania, and 3% European. Of all anemia cases, 97% are found in middle-income countries \[[@b5-ogs-19196]\]. Anemia is particularly prevalent in women of reproductive age and children under the age of 5. Studies in developed countries such as Japan, Sweden, and the United States indicate the rising incidence of iron deficiency anemia in affluent societies. It has also posed a major problem in developing countries such as India over the last 50 years \[[@b6-ogs-19196]\].

The results of a study in 185 countries from 1990 to 2011 exhibited that anemia was the most prevalent in Southeast Asia. Extreme cases of iron deficiency anemia can escalate to maternal mortality and preterm labor \[[@b3-ogs-19196],[@b7-ogs-19196]\]. Several factors contribute to the widespread prevalence of micronutrient deficiencies in South Asia including iron deficiency in the diet, poor health, genetic causes, chronic infections, malaria and schistosomiasis \[[@b8-ogs-19196],[@b9-ogs-19196]\]. The prevalence of anemia varies widely in different parts of the world and it is more salient in lower socioeconomic classes \[[@b10-ogs-19196]\].

Moreover, as far as the relationship between anemia and the human development index (HDI) is concerned, in areas with a high HDI, anemia-related problems are less noticeable. HDI represents the essence of human development measures. This index measures the average success of a country in 3 main dimensions of human development, i.e. a long and healthy life, education and appropriate living standards \[[@b11-ogs-19196]\].

Given the prevalence of anemia in Asian countries, it is necessary to raise awareness about its contributing factors in order to plan and manage the financial and human resources required to curb its incidence. It is essential for countries to introduce the necessary interventions by comparing their data with those of other countries with regard to the effect of socioeconomic status on the root causes of anemia \[[@b11-ogs-19196]\].

The purpose of this study was to explore the impact of socioeconomic development (based on HDI) on the prevalence of anemia among Asian women based on data retrieved from the World Bank in 2018.

Materials and methods
=====================

The present research was a descriptive-analytic ecological study that investigated the relationship between anemia prevalence in 3 groups of women and its connection with HDI in Asian countries. The study data included HDI and the prevalence of anemia obtained from the World Bank \[[@b12-ogs-19196]\].

1. Definition of anemia
-----------------------

Percentage of women aged 15−49 years with a hemoglobin concentration less than 120 g/L for non-pregnant women and lactating women and less than 110 g/L for pregnant women, adjusted for altitude and smoking \[[@b13-ogs-19196],[@b14-ogs-19196]\].

2. Human development index
--------------------------

The HDI provided by the World Bank delivers the latest data on global development, which includes national, regional and global estimates. According to the Human Development Report, countries are divided into 4 groups: very high human development, high human development, medium human development, and low human development based on the level of the HDI. The numerical value of the HDI is between 0 and 1. It measures efforts taken by each country to reach the highest possible HDI value, and also allows comparisons between countries. HDI represents the essence of human development measures. It measures the mean success of a country in 3 main dimensions of human development: a long and healthy life, access to education and proper living standards \[[@b15-ogs-19196]\].

3. Statistical analysis
-----------------------

In this study, data analysis was performed using correlation coefficients and an analysis of variance (ANOVA) to investigate the relationship between the prevalence of anemia and HDI. A *P*-value of less than 0.05 was considered significant. Analyses were performed using the Stata-14 software (StataCorp, College Station, TX, USA).

Results
=======

According to the results reported in 2016, the global prevalence of anemia is 32.5% in non-pregnant women, 40.1% in pregnant women, and 32.8% in women of reproductive age. The highest prevalence of anemia in all 3 groups of women (non-pregnant, pregnant, and of reproductive age) was observed in South-East Asia and the lowest in America ([Table 1](#t1-ogs-19196){ref-type="table"}). The analysis of trends in anemia prevalence in 3 groups of women between 2000 and 2016 demonstrates that the prevalence of anemia in all 3 groups was the highest in the South-East Asia region, which was above the global average during these years ([Fig. 1](#f1-ogs-19196){ref-type="fig"}).

According to the analysis of the prevalence of anemia, the highest prevalence of anemia in non-pregnant women was recorded in Yemen (70.2%), Pakistan (52.2%), and India (51.5%); the highest prevalence of anemia in pregnant women was recorded in Yemen (63%), Cambodia (55.8%), and Myanmar (53.8%); and the highest prevalence of anemia in women of reproductive age was recorded in Yemen (69.6%), Pakistan (52.1%), and India (51.4%) ([Table 2](#t2-ogs-19196){ref-type="table"}).

The results revealed a significant negative correlation between the prevalence of anemia in women of reproductive age (R=−0.626, *P*\<0.001), pregnant women (R=−0.576, *P*\<0.001) and non-pregnant women (R=−0.623, *P*\<0.001) and HDI index ([Fig. 2](#f2-ogs-19196){ref-type="fig"}).

In the analysis of HDI components and the prevalence of anemia in 3 groups of women, a significant negative correlation was observed between the prevalence of anemia in non-pregnant women and mean years of schooling (MYS) (r=−0.564, *P*\<0.001), life expectancy at birth (LEB) (r=−0.552, *P*\<0.001), and expected years of schooling (EYS) (r=−0.564, *P*\<0.001). There was a significant negative correlation between anemia prevalence in pregnant women and MYS (r=−0.563, *P*\<0.001), LEB (r=−0.439, *P*\<0.001), and EYS (r =−0.534, *P*\<0.01). Moreover, there was also a significant negative correlation between the prevalence of anemia in women of reproductive age and MYS (r=−0.567, *P*\<0.001), LEB (r=−0.553, *P*\<0.001), and EYS (r=−0.566, *P*\<0.01). No significant correlation was observed between the prevalence of anemia and GDP in all 3 groups of women (P\>0.05) ([Table 3](#t3-ogs-19196){ref-type="table"}).

The results of the ANOVA suggested that in non-pregnant women, the highest mean prevalence (48.7±19.1) belonged to low human development and the lowest mean prevalence (27.4±9.2) to very high human development, and this difference was statistically significant (F=4.73, *P*\<0.001). In pregnant women, the highest mean (45.7±8.6) belonged to low human development and the lowest mean (33.8±6.6) to very high human development, and the difference was statistically significant (F=4.11, *P*\<0.001). These results were comparable to those found in women of reproductive age, with the highest mean prevalence of anemia (48.8±18.8) belonging to low human development and the lowest mean prevalence to the very high human development (27.6±9.1). Here, the difference was also statistically significant (F=4.73, *P*\<0.001) ([Table 4](#t4-ogs-19196){ref-type="table"}).

Discussion
==========

Iron deficiency anemia has been reported in 25% of mothers with malnutrition \[[@b3-ogs-19196]\]. Pregnant women and young children are more likely to develop anemia. Geographically, people living in Asia and Africa are at a greater risk of anemia. According to the WHO, the prevalence of anemia in all women, pregnant women, and non-pregnant women was 37%, 51%, and 35%, respectively, in 1988 \[[@b16-ogs-19196]\]. The results of this research suggested that, in general, the highest prevalence of anemia in non-pregnant women, pregnant woman, and women of reproductive age was observed in Asia, Africa, and Asia, respectively. Moreover, the highest prevalence of anemia in non-pregnant women (70.2%), pregnant women (63%), and women of reproductive age (69.6%) was recorded in Yemen.

The lowest incidence of anemia in non-pregnant women was recorded in the Philippines (14.9%); in pregnant women in Israel (23.8%); and in women of reproductive age in Japan and the Philippines (15.7%).

The difference in the prevalence of anemia in these areas can also be attributed to differences in the socioeconomic status of individuals. One indicator that reflects the status of countries is HDI. This index explores the status of a country in 3 key development dimensions, including health, education and living standards. Health is measured with LEB, education with the EYS, and living standards as gross national income per capita or GDP. In countries with high HDI, the prevalence of anemia is lower. The secondary causes of anemia prevalence include timely screening and diagnosis, elevated quality of food, early-stage treatment of malnutrition, and accurate estimation of vitamin intake in these countries \[[@b9-ogs-19196]\].

In middle-income countries, the prevalence of anemia is higher; as a result, 97% of anemia-induced mortality is reported in developing countries \[[@b5-ogs-19196]\]. The highest prevalence of anemia in the world is observed in countries with low HDI \[[@b17-ogs-19196]\]. In this context, the highest prevalence of anemia has been recorded in Asian countries. Nutritional anemia is widespread not only in developing countries but also in affluent societies \[[@b2-ogs-19196],[@b16-ogs-19196]\].

The results of a 2016 study by Petry et al. \[[@b4-ogs-19196]\] demonstrated that anemia has declined in countries with moderate to high HDI. In this study, iron deficiency anemia in preschool children and women of reproductive age was 25% and 37% in high HDI communities, respectively, while this figure was higher than the 45% in low HDI communities. A 2011 study by Oliveira et al. \[[@b18-ogs-19196]\] showed that there was an inverse association between the prevalence of anemia and HDI. This study revealed that the prevalence of anemia was significantly higher among blood donors in communities with lower HDI \[[@b18-ogs-19196]\]. In their 2012 study, Laxmaiah et al. \[[@b19-ogs-19196]\] exhibited that the incidence of HDI was inversely correlated with the prevalence of anemia. These studies demonstrated that anemia is still a major health issue and the prevention and control of malnutrition should be considered as a key strategy in curbing the prevalence of anemia.

Socioeconomic developments have wielded huge influence on the prevalence of anemia. In low- and middle-income countries, the risk of anemia is increasing. Socioeconomic growth is inversely related to the prevalence of anemia. Chronic infections, nutritional disorders, obesity, chronic noncommunicable diseases, thalassemia, and genetic susceptibility are among the risk factors for anemia. Anemia is linked to HDI in societies, so that according to statistics, the most anemia-related deaths take place in less developed countries \[[@b4-ogs-19196]\].

The results of this study demonstrate a significant negative correlation between the prevalence of anemia in non-pregnant women and MYS (r=−0.564, *P*\<0.001), LEB (r=−0.552, *P*\<0.001), and EYS (r=−0.564, *P*\<0.001); a significant negative correlation between anemia prevalence in pregnant women and MYS (r=−0.563, *P*\<0.001), LEB (r=−0.439, *P*\<0.001), and EYS (r=−0.534, *P*\<0.01), and a significant negative correlation between the prevalence of anemia in women of reproductive age and MYS (r=−0.567, *P*\<0.001), LEB (r=−0.553, *P*\<0.001), and EYS (r=−0.566, *P*\<0.01). The lower prevalence of anemia in countries with higher HDIs could be attributed to factors such as the existence of micronutrients in foods, more accurate diagnostic methods and enhanced access to primary health care.

The major factors contributing to the high prevalence of anemia in most countries are low income levels and malnutrition. Hence, one effective step to mitigate the prevalence of anemia is to provide primary anemia prevention strategies such as increasing household per capita and providing food packages for families. Despite the interrelation of these factors, caution should be practiced when interpreting such studies because, in addition to the environmental factors of anemia prevalence, the limitations of descriptive studies should also be taken into consideration. Early prevention and epidemiological studies, especially for people in less developed countries, can help reduce the burden of disease and improve health status in these countries.

In women from different south-east Asian regions iron deficiency anemia should ideally be addressed through dietary diversification and improved access to foods that have high levels of bioavailable iron, including animal products. Daily or intermittent iron supplementation, alone or together with folic acid and other micronutrients, can be used for high-risk groups (children, pregnant women and women of reproductive age), to improve iron intake. These strategies should be tailored to local conditions, taking into account the specific etiology and prevalence of anemia in a given setting and population group, and should be built into the primary health-care system and existing programs.

In conclusion, the results of the present study suggest a negative correlation between the prevalence of anemia in women and HDI. Moreover, the prevalence of anemia in these countries was negatively correlated with LEB and education. Hence, a study of factors that raise the prevalence of anemia in countries with low HDI can go a long way in reducing its incidence rate. Further, raising the level of a mother's education and her awareness can also contribute to a reduced incidence.
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###### 

Prevalence of anemia in women estimates by World Health Organization (WHO) region

  WHO region              Prevalence of anemia in non-pregnant woman (%)   Prevalence of anemia in pregnant woman (%)   Prevalence of anemia in woman reproductive age (%)                                                                                                                                                                                                                    
  ----------------------- ------------------------------------------------ -------------------------------------------- ---------------------------------------------------- ------------------ ------------------ ------------------ ------------------ ------------------ ------------------ ------------------ ------------------ ------------------ ------------------ ------------------ ------------------
  Africa                  44.8 (39.8-49.0)                                 42.6 (38.2-46.5)                             39.1 (34.7-43.2)                                     38.0 (32.0-44.1)   38.2 (31.7-45.0)   52.1 (48.9-54.9)   50.5 (47.6-52.9)   48.1 (44.8-50.7)   46.3 (41.0-50.7)   46.2 (40.3-51.3)   45.6 (41.0-49.5)   43.4 (39.3-47.0)   40.1 (36.0-43.9)   38.8 (33.1-44.5)   39.0 (32.7-45.4)
  America                 19.8 (16.5-23.7)                                 18.7 (16.1-21.5)                             17.5 (14.5-21.1)                                     18.2 (13.5-24.7)   18.8 (13.5-26.4)   28.9 (22.9-34.5)   26.8 (21.7-31.7)   25.4 (20.5-30.4)   25.3 (19.5-32.3)   25.5 (19.2-32.8)   20.2 (17.0-24.0)   19.1 (16.5-21.7)   17.8 (14.9-21.3)   18.4 (13.9-24.8)   19.1 (13.9-26.5)
  South-East Asia         47.4 (42.3-52.2)                                 46.5 (41.1-51.2)                             44.9 (39.4-50.2)                                     45.2 (39.0-50.2)   45.6 (38.8-51.2)   50.3 (45.6-55.1)   49.2 (43.8-53.6)   48.0 (42.5-52.8)   47.9 (42.3-53.1)   48.1 (42.1-53.7)   47.6 (42.7-52.2)   46.7 (41.4-51.2)   45.0 (39.7-50.2)   45.3 (39.3-50.2)   45.8 (39.1-51.2)
  Europe                  20.2 (16.1-25.5)                                 19.8 (16.0-25.0)                             19.5 (15.7-24.5)                                     21.7 (16.2-28.8)   22.5 (16.4-30.7)   27.5 (22.0-33.6)   26.0 (21.2-31.5)   25.3 (20.6-31.1)   26.1 (20.3-33.9)   26.5 (20.3-35.0)   20.4 (16.3-25.6)   20.0 (16.2-25.1)   19.7 (15.9-24.5)   21.8 (16.4-28.7)   22.7 (16.6-30.7)
  Eastern Mediterranean   39.3 (34.7-43.6)                                 38.4 (34.0-42.8)                             37.4 (32.9-41.8)                                     39.0 (32.2-45.6)   39.8 (32.1-47.5)   41.1 (36.4-45.7)   40.5 (36.6-44.5)   40.1 (36.1-43.8)   40.6 (34.9-46.5)   40.9 (34.5-47.6)   39.5 (35.0-43.7)   38.6 (34.4-42.8)   37.6 (33.3-41.8)   39.1 (32.6-45.5)   39.8 (32.4-47.4)
  Western Pacific         21.8 (15.7-30.7)                                 19.4 (13.8-28.3)                             19.2 (12.5-29.4)                                     23.7 (12.5-38.8)   25.1 (12.5-41.8)   28.9 (23.4-36.6)   27.7 (22.1-35.4)   28.3 (20.9-39.1)   32.0 (20.5-49.3)   33.0 (20.5-51.1)   22.0 (16.0-30.8)   19.6 (14.2-28.4)   19.5 (12.8-29.6)   23.9 (12.9-38.6)   25.3 (13.0-41.8)
  World                   31.1 (28.5-34.2)                                 30.1 (27.6-33.1)                             29.4 (26.6-32.9)                                     31.6 (27.4-36.4)   32.5 (27.8-37.8)   41.6 (39.1-44.0)   40.4 (38.1-42.8)   39.4 (36.9-42.1)   39.8 (36.4-43.8)   40.1 (36.4-44.6)   31.6 (29.1-34.7)   30.6 (28.2-33.5)   29.9 (27.2-33.3)   32.0 (27.9-36.6)   32.8 (28.3-38.0)

###### 

Prevalence of anemia in Asian women (estimates by country in 2016)

  Country                            Prevalence of anemia in non-pregnant woman (%)   Prevalence of anemia in pregnant woman (%)   Prevalence of anemia in woman reproductive age (%)
  ---------------------------------- ------------------------------------------------ -------------------------------------------- ----------------------------------------------------
  Afghanistan                        42.4 (27.7--55.8)                                38.2 (24.7--53.3)                            42.0 (28.2--54.9)
  Armenia                            29.2 (12.2--56.3)                                35.5 (17.5--63.3)                            29.4 (12.6--56.3)
  Azerbaijan                         38.4 (25.3--51.8)                                40.1 (26.9--54.7)                            38.5 (25.7--51.6)
  Bahrain                            41.9 (19.0--67.2)                                42.8 (20.2--64.8)                            42.0 (19.7--66.7)
  Bangladesh                         39.6 (21.1--55.5)                                45.7 (28.9--60.1)                            39.9 (22.0--55.5)
  Bhutan                             35.7 (24.8--47.8)                                32.8 (21.3--47.9)                            35.6 (25.0--47.3)
  Cambodia                           46.3 (36.3--54.2)                                55.8 (46.0--63.3)                            46.8 (37.2--54.6)
  China                              26.2 (9.8--47.7)                                 32.4 (15.6--57.8)                            26.4 (10.2--47.5)
  Cyprus                             25.1 (9.6--50.6)                                 29.0 (15.2--57.0)                            25.2 (9.9--50.2)
  Georgia                            27.4 (12.9--45.5)                                30.1 (17.5--50.3)                            27.5 (13.2--45.3)
  India                              51.5 (41.5--58.7)                                50.1 (42.0--57.2)                            51.4 (41.8--58.5)
  Indonesia                          28.2 (18.7--38.8)                                42.0 (30.4--53.7)                            28.8 (19.4--39.0)
  Iran                               30.3 (12.7--52.8)                                34.1 (17.5--57.6)                            30.5 (13.2--52.4)
  Iraq                               28.7 (17.2--44.3)                                33.5 (19.3--51.6)                            29.1 (18.0--44.1)
  Israel                             15.2 (7.0--38.0)                                 23.8 (12.7--49.9)                            15.7 (7.5--37.3)
  Japan                              21.2 (14.4--31.0)                                34.1 (18.2--57.6)                            21.5 (14.8--31.0)
  Jordan                             34.5 (20.8--50.0)                                37.1 (22.9--51.6)                            34.7 (21.4--49.7)
  Kazakhstan                         30.7 (13.0--52.2)                                30.4 (15.7--54.3)                            30.7 (13.4--51.2)
  Kuwait                             23.5 (9.8--46.3)                                 31.2 (14.8--57.3)                            23.8 (10.2--46.2)
  Kyrgyzstan                         35.9 (21.3--51.5)                                39.8 (25.1--55.6)                            36.2 (22.0--51.0)
  Lao People's Democratic Republic   39.3 (19.5--60.7)                                45.7 (23.8--65.0)                            39.7 (20.7--60.7)
  Lebanon                            31.1 (13.2--55.0)                                35.2 (17.8--60.1)                            31.2 (13.6--54.8)
  Malaysia                           24.4 (9.4--49.8)                                 37.1 (15.8--63.0)                            24.9 (10.0--49.7)
  Maldives                           42.4 (21.2--60.9)                                46.9 (18.6--67.5)                            42.6 (21.9--61.0)
  Mongolia                           18.9 (7.1--38.8)                                 30.3 (18.2--49.5)                            19.5 (8.0--38.4)
  Myanmar                            46.0 (34.2--54.7)                                53.8 (41.5--62.4)                            46.3 (35.0--54.9)
  Nepal                              34.9 (19.2--50.9)                                40.0 (22.9--57.7)                            35.1 (19.9--50.9)
  Oman                               38.0 (17.4--62.2)                                41.8 (20.8--62.5)                            38.2 (18.1--62.1)
  Pakistan                           52.2 (35.3--67.4)                                51.3 (36.4--62.8)                            52.1 (35.7--67.0)
  Philippines                        14.9 (9.7--25.6)                                 30.3 (19.2--45.2)                            15.7 (10.5--26.1)
  Qatar                              27.5 (10.2--52.8)                                33.4 (15.2--58.5)                            27.7 (10.6--52.9)
  Saudi Arabia                       42.8 (18.0--70.9)                                45.5 (20.7--65.6)                            42.9 (18.8--70.5)
  Singapore                          22.0 (8.5--50.3)                                 31.8 (15.2--59.6)                            22.2 (8.7--50.3)
  Sri Lanka                          32.5 (14.1--51.3)                                35.4 (19.2--55.6)                            32.6 (14.7--51.1)
  Syrian Arab Republic               33.5 (13.8--56.5)                                36.1 (17.2--60.2)                            33.6 (14.6--56.3)
  Tajikistan                         30.3 (14.0--49.3)                                33.5 (17.3--57.4)                            30.5 (14.9--48.5)
  Thailand                           31.6 (11.2--70.2)                                40.2 (15.9--67.6)                            31.8 (11.7--70.2)
  Timor-Leste                        41.2 (25.0--55.9)                                42.6 (24.5--60.7)                            41.3 (26.2--55.9)
  Turkey                             30.7 (12.0--56.7)                                34.4 (16.5--60.2)                            30.9 (12.5--56.6)
  Turkmenistan                       32.6 (13.3--54.9)                                33.1 (16.7--58.1)                            32.6 (13.8--54.4)
  United Arab Emirates               27.6 (10.8--52.7)                                33.2 (15.7--59.6)                            27.8 (11.1--52.6)
  Uzbekistan                         36.8 (16.2--52.6)                                24.9 (14.6--48.5)                            36.2 (16.6--51.6)
  Viet Nam                           23.7 (10.4--43.7)                                37.3 (19.3--58.5)                            24.2 (11.0--43.8)
  Yemen                              70.2 (54.7--79.7)                                63.0 (56.3--66.7)                            69.6 (55.0--78.5)

###### 

Pearson correlation between human development index (HDI) component and prevalence of anemia in Asian women in 2016

  HDI component                            Prevalence of anemia in non-pregnant woman (%)   Prevalence of anemia in pregnant woman (%)   Prevalence of anemia in woman reproductive age (%)                      
  ---------------------------------------- ------------------------------------------------ -------------------------------------------- ---------------------------------------------------- --------- -------- ---------
  Gross national income per 1,000 capita   −0.284                                           \>0.05                                       −0.225                                               \>0.05    −0.286   \>0.05
  Mean years of schooling                  −0.564                                           \<0.001                                      −0.563                                               \<0.001   −0.567   \<0.001
  Life expectancy at birth                 −0.552                                           \<0.001                                      −0.439                                               \<0.001   −0.553   \<0.001
  Expected years of schooling              −0.564                                           \<0.001                                      −0.534                                               \<0.001   −0.566   \<0.001

Statistical method used: Pearson correlation coefficient.

###### 

Prevalence of anemia in different human development index (HDI) regions Asian women in 2016

  HDI                                                              Prevalence of anemia in non-pregnant woman (%)   Prevalence of anemia in pregnant woman (%)   Prevalence of anemia in woman reproductive age (%)
  ---------------------------------------------------------------- ------------------------------------------------ -------------------------------------------- ----------------------------------------------------
  Very high human development                                      27.4±9.2                                         33.8±6.6                                     27.6±9.1
  High human development                                           31.4±5.8                                         35.3±5.3                                     31.6±5.6
  Medium human development                                         36.3±10                                          41.7±8.1                                     36.5±9.8
  Low human development                                            48.7±19.1                                        45.7±8.6                                     48.8±18.8
  *P*-value (F-test)^[a)](#tfn2-ogs-19196){ref-type="table-fn"}^   \<0.001                                          \<0.001                                      \<0.001

Data are shown as mean±standard deviation.

Statistical method used: analysis of variance.
